Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development
The National Cancer Institute is conducting market research to identify large and small businesses capable of providing registration, storage, and distribution support for chemicals and drugs used in preclinical discovery and development. The work supports operation and maintenance of the NCI Chemotherapeutic Agents Repository, including investigator interface, chemical/inventory database updates, records management, sample reacquisition, and receipt/storage/distribution of research compounds. The repository curates roughly 500,000–600,000 samples; about 400 samples are received, registered, and shipped monthly to NCI testing facilities, and an additional 2,500 samples are weighed monthly and shipped to U.S. and foreign investigators. The program acquires and evaluates about 5,000 single agents annually in anticancer assays and provides vialed and plated research samples to the community. This is not a solicitation; NCI may issue an RFP, and all Small Business Set-Aside categories will be considered.